These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 33324150)

  • 21. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra.
    Chatha BT; Bernard V; Streit P; Bolam JP
    Neuroscience; 2000; 101(4):1037-51. PubMed ID: 11113353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study.
    Kritis AA; Stamoula EG; Paniskaki KA; Vavilis TD
    Front Cell Neurosci; 2015; 9():91. PubMed ID: 25852482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and morphological analysis of non-NMDA receptor mediated excitotoxicity in chick embryo retina.
    Chen Q; Olney JW; Price MT; Romano C
    Vis Neurosci; 1999; 16(1):131-9. PubMed ID: 10022484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemia enhances ionotropic but reduces metabotropic glutamate responses in substantia nigra dopaminergic neurons.
    Marinelli S; Federici M; Giacomini P; Bernardi G; Mercuri NB
    J Neurophysiol; 2001 Mar; 85(3):1159-66. PubMed ID: 11247985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.
    Rodriguez MC; Obeso JA; Olanow CW
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S175-88. PubMed ID: 9749591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases.
    Armada-Moreira A; Gomes JI; Pina CC; Savchak OK; Gonçalves-Ribeiro J; Rei N; Pinto S; Morais TP; Martins RS; Ribeiro FF; Sebastião AM; Crunelli V; Vaz SH
    Front Cell Neurosci; 2020; 14():90. PubMed ID: 32390802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.
    Bonsi P; Cuomo D; Picconi B; Sciamanna G; Tscherter A; Tolu M; Bernardi G; Calabresi P; Pisani A
    Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity.
    Massie A; Schallier A; Kim SW; Fernando R; Kobayashi S; Beck H; De Bundel D; Vermoesen K; Bannai S; Smolders I; Conrad M; Plesnila N; Sato H; Michotte Y
    FASEB J; 2011 Apr; 25(4):1359-69. PubMed ID: 21191088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease.
    Blandini F
    Funct Neurol; 2010; 25(2):65-71. PubMed ID: 20923603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participation of Glutamatergic Ionotropic Receptors in Excitotoxicity: The Neuroprotective Role of Prolactin.
    Rodriguez-Chavez V; Moran J; Molina-Salinas G; Zepeda Ruiz WA; Rodriguez MC; Picazo O; Cerbon M
    Neuroscience; 2021 May; 461():180-193. PubMed ID: 33647379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling.
    Liu Y; Wang S; Kan J; Zhang J; Zhou L; Huang Y; Zhang Y
    Curr Neuropharmacol; 2020; 18(4):260-276. PubMed ID: 31686629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis.
    Bazan NG; Tu B; Rodriguez de Turco EB
    Prog Brain Res; 2002; 135():175-85. PubMed ID: 12143339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis and glutamate excitotoxicity.
    Kostic M; Zivkovic N; Stojanovic I
    Rev Neurosci; 2013; 24(1):71-88. PubMed ID: 23152401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential postreceptor signaling events triggered by excitotoxic stimulation of different ionotropic glutamate receptors in retinal neurons.
    Santos AE; Carvalho AL; Lopes MC; Carvalho AP
    J Neurosci Res; 2001 Nov; 66(4):643-55. PubMed ID: 11746384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical localization of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat.
    Albers DS; Weiss SW; Iadarola MJ; Standaert DG
    Neuroscience; 1999 Mar; 89(1):209-20. PubMed ID: 10051230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate receptors, neurotoxicity and neurodegeneration.
    Lau A; Tymianski M
    Pflugers Arch; 2010 Jul; 460(2):525-42. PubMed ID: 20229265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.
    Savolainen MH; Albert K; Airavaara M; Myöhänen TT
    Exp Brain Res; 2017 Jul; 235(7):2189-2202. PubMed ID: 28439627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.